GrantForecasted — not yet openSmall businesses not listed as eligible
Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
National Institutes of Health
Program funding
$19,100,000
- Opportunity #
- RFA-CA-25-035
- Agency
- National Institutes of Health
- ALN (CFDA)
- 93.394
- Status
- forecasted
- Posted
- Jan 13, 2026
- Funding instrument
- Cooperative Agreement
- Category
- Health
- Cost sharing required
- No
Who can apply
- •Others (see text field entitled "Additional Information on Eligibility" for clarification)
Other Eligible ApplicantsFor the NCTN Biobanks: Eligibility is limited to an institution/entity that is a recipient of an existing NCTN biobank of human biospecimens from NCI clinical trials funded under RFA-CA-20-002. For the EET Biobank: Eligibility is limited to the institution/entity that is a recipient of an existing EET biobank of human biospecimens from NCI clinical trials funded under RFA-CA-20-003.
Contact
NCI DCTD CDP PIRB NOFO · NCICDPNOFO@mail.nih.gov